|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 顽固性高血压与由心内容积决定的血管内液体潴留无关显示文摘顽固性高血压(refractory hypertension,RfHTN)是一种极端的抗高血压治疗失败的表现形式,定义为使用了包括长效噻嗪类和盐皮质激素受体拮抗剂在内的≥5种药时血压仍控制欠佳。RfHTN是难治性高血压(resistant hypertension,RHTN)的一个亚组,RHTN定义为使用≥3种降压药(包括利尿剂)后血压仍〉135/85mm Hg(1mm Hg=0.133kPa)。 | 刘青 叶鹏 Velasco A Siddiqui M Kreps E Kolakalapudi P Dudenbostel T Arora G Judd EK Prabhu SD Lloyd SG Oparil S Calhoun DA | 2018 | 中华高血压杂志2018，26，7： | 2 |
| 2 | Aldosteronism and hypertension 显示文摘 | Calhoun DA | 2006 | Clin J Am Soc Nephrol2006，1，5： | 1 |
| 3 | Resistant hypertension: diagnosis, evaluation, and treatment, hypertension (AHA scien- tific statement)显示文摘 | Calhoun DA Jones D Textor S | 2008 | Hypertension2008，51，6： | 1 |
| 4 | Aldosterone antagonism : an emerging strategy for effective blood pressure lowering显示文摘 | Pratt-Ubunama MN Nishizaka MK Calhoun DA | 2005 | Curt Hypertens Rep2005，7，： | 1 |
| 5 | Resistant Hypertension and Hyperaldosteronism显示文摘 | Gonzaga CC Calhoun DA | 2008 | Curr Hyperten Rep2008，10，6： | 1 |
| 6 | Resistant hypertension,obesity,sleep apnea,and aldosterone:theory and therapy显示文摘 | Goodfriend TL Calhoun DA | 2004 | Hypertension2004，43，3： | 1 |
| 7 | Resistant hypertension : diagnosis, evaluation, and treatment显示文摘 | Calhoun DA Jones D Textor S | 2008 | Hypertension2008，51，： | 1 |
| 8 | Hyperaldoste-ronism among black and white subjects with resistant hyperten-sion显示文摘 | Calhoun DA Nishizaka MK Zaman MA | 2002 | Hypertension2002，40，6： | 1 |
| 9 | Managing the patients with hard-to-control hypertension显示文摘 | Oparil S Calhoun DA | 1998 | Am Fam Physician1998，57，5： | 1 |
| 10 | Plasma thrombopoi- etin concentrations in thrombocytopenic and non - thrombo- cytopenic patients in a neonatal intensive care unit 显示文摘 | Sola MC Calhoun DA Hutson AD | 1999 | Br J Haematol1999，104，： | 1 |
| 11 | Is there an unrecognized epidemic of primary aldo- steronism? 显示文摘 | Calhoun DA | 2007 | Hypertension2007，50，3： | 1 |
| 12 | Hyperaldosteronism among black and white subjects with resistant hypertension显示文摘 | Calhoun DA Nishizaka MK Zaman MA | 2002 | Hypertension2002，40，6： | 1 |
| 13 | Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea 显示文摘 | Calhoun DA Nishizaka MK Zaman MA | 2004 | Chest2004，125，1： | 1 |
| 14 | Efficacy of low-dose spironolactone in subjects with resistant hypertension显示文摘 | Nishzaka MK Zaman MA Calhoun DA | 2003 | Am J Hypertens2003，16，111： | 1 |
| 15 | Resistant Hypertension: Diagnosis, Evaluation, and Treatment: a Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research显示文摘 | Calhoun DA Jones D Textor S | 2008 | Circulation2008，117，25： | 1 |
| 16 | Resistant hypertension: who and how to evaluate显示文摘 | Acelajado MC Calhoun DA | 2009 | Curr Opin Cardiol2009，24，4： | 1 |
| 17 | Hyperaldosteronism among blacks and whites subjects with resistant hypertension显示文摘 | Calhoun DA Nishizaka Mk Zaman MA | 2002 | Hypertension2002，40，： | 1 |
| 18 | Resistant hypertension, obesity, sleep apnea and aldosterone: theory and therapy显示文摘 | Goodfriend TL Calhoun DA | 2004 | Hypertension2004，43，： | 1 |
| 19 | Sleep apnea, aldosterone,and resistant hypertension显示文摘 | Pimenta E Calhoun DA Oparil S | 2009 | Prog Cardiovasc Dis2009，51，5： | 1 |
| 20 | Resistant hypertension, obstructive sleep apnoea and aldosterone显示文摘 | Dudenbostel T Calhoun DA | 2012 | J Hum Hypertens2012，26，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员